Literature DB >> 6804143

Isolation and characterization of circulating immune complexes in cystic fibrosis.

R B Moss, Y P Hsu.   

Abstract

A methodology for the isolation and immunologic characterization of IgG-containing circulating immune complexes (IgG-CIC) as detected by the 125IClq-binding assay (ClqBA) is described. We applied this methodology to sera from patients with cystic fibrosis (CF), both positive and negative for IgG-CIC. We used latex-fixation-positive rheumatoid arthritis sera and normal human sera as positive and negative controls, respectively. All IgG-CIC-positive serum samples from CF patients were found to contain antibodies against Pseudomonas aeruginosa in the isolated complexes. Some patients also had antibodies in CIC specific for Staphylococcus aureus and Candida albicans. CIC specificity corresponded to respiratory tract colonization for each patient.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6804143      PMCID: PMC1536527     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  25 in total

Review 1.  The biology and detection of immune complexes.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Adv Immunol       Date:  1979       Impact factor: 3.543

2.  Isolation and characterization of soluble insulin-anti-insulin immune complexes formed in vitro and in vivo in sera from patients with diabetes mellitus.

Authors:  J M Kilpatrick; G Virella
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

3.  Antigen-specific detection of HBsAG-containing immune complexes in the course of hepatitis B virus infection.

Authors:  W Pernice; C P Sodomann; G Lüben; F R Seiler; H H Sedlacek
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

4.  ELISA methodology for polysaccharide antigens: protein coupling of polysaccharides for adsorption to plastic tubes.

Authors:  B M Gray
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

5.  Longitudinal study of circulating immune complexes in a patient with Staphylococcus albus-induced shunt nephritis.

Authors:  G D Harkiss; D L Brown; D B Evans
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

6.  Purification of soluble immune complexes from serum using polymethylmetacrylate beads coated with conglutinin or C1q. Application to the analysis of the components of in vitro formed immune complexes and of immune complexes occurring in vivo during leishmaniasis.

Authors:  P Casali; P H Lambert
Journal:  Clin Exp Immunol       Date:  1979-08       Impact factor: 4.330

7.  Immune complexes and humoral response to Pseudomonas aeruginosa in cystic fibrosis.

Authors:  R B Moss; N J Lewiston
Journal:  Am Rev Respir Dis       Date:  1980-01

8.  Thermodissociation of staphylococcal immune complexes and detection of staphylococcal antigen in serum from patients with Staphylococcus aureus bacteremia.

Authors:  Z A Tabbarah; L J Wheat; R B Kohler; A White
Journal:  J Clin Microbiol       Date:  1980-06       Impact factor: 5.948

9.  Circulating immune complexes in coccidioidomycosis. Detection and characterization.

Authors:  S Yoshinoya; R A Cox; R M Pope
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

10.  Circulating immune complexes in cystic fibrosis.

Authors:  M Berdischewsky; M Pollack; L S Young; D Chia; A B Osher; E V Barnett
Journal:  Pediatr Res       Date:  1980-06       Impact factor: 3.756

View more
  5 in total

Review 1.  Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

Authors:  D P Greenberg; H R Stutman
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

Review 2.  Chronic suppurative lung disease with associated vasculitis.

Authors:  I N Bruce; J A McAteer; P V Gardiner; R J McFarland; J M Sloan; A L Bell
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

3.  Combined evaluation of circulating immune complexes and antibodies to Pseudomonas aeruginosa as an immunologic profile in relation to pulmonary function in cystic fibrosis.

Authors:  M K Dasgupta; P Zuberbuhler; A Abbi; F L Harley; N E Brown; K Lam; J B Dossetor; J W Costerton
Journal:  J Clin Immunol       Date:  1987-01       Impact factor: 8.317

4.  Immune complexes and Pseudomonas aeruginosa antibodies in cystic fibrosis.

Authors:  H P Van Bever; P L Gigase; L S De Clerck; C H Bridts; H Franckx; W J Stevens
Journal:  Arch Dis Child       Date:  1988-10       Impact factor: 3.791

5.  The effect of Pseudomonas alginate on rat alveolar macrophage phagocytosis and bacterial opsonization.

Authors:  A M Oliver; D M Weir
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.